Uptake of V3Hjoleate by canine or rat cardiac myocytes is saturable, displays the countertransport phenomenon, and is inhibited by phloretin and trypsin. Cardiac myocytes contain a basic (pI 9.1) 40-kD plasma membrane fatty atid binding protein (FABPpM) analogous to those recently isolated from liver, adipose tissue, and gut, unrelated to the 12-14-kD cytosolic FAIRP in these same tissues. An antibody to rat liver FABPpM selectively inhibits specific uptake of [3Hfoleate by rat heart myocytes at 370C, but has no influence on nonspecific VHoleate uptake at 40C or on specific uptake of VHjglucose. Uptake of long-chain free fatty acids by cardiac muscle cells, liver, and adipose tissue and absorption by gut epithelial cells is a facilitated process mediated by identical or closely related plasma membrane FABPs.
Introduction
Even though the heart capillary endothelitum represents a barrier to free fatty acid (FFA) extraction by the myocyte (1, 2), uptake rates in vivo are substantial (1) . Indeed, FFA represent the most important substrate for myocardial energy metabolism under basal conditions. With regard to the mechanism of FFA uptake, some have suggested that the transfer of FFA from plasma into the cell is carrier mediated (3, 4) whereas others argue that the process is equilibrative and that the kinetics observed reflect intracellular metabolism rather than membrane transport (5, 6) . However, earlier studies (5, 6) of cardiac FFA uptake employed Ca2 -intolerant myocytes in which sarcolemma permeability is altered (7) . They also failed to consider the contribution of rapid efflux to the shape of the FFA uptake curve. Hence, the nature of the uptake process in cardiac myocytes remains uncertain. By contrast, studies from several laboratories, including our own, have documented that FFA uptake by hepatocytes (8, 9 ) and adipocytes (10-12) is unequivocally carrier mediated, and that a 40-kD plasma membrane fatty acid binding protein (fPABPpM)' isolated from these tissues and from the gut (12) (13) (14) plays an essential role in fatty acid uptake (8, 9, 12, 15) . The aims of the present study were, therefore (a) to study the uptake ofa representative FFA,
[3H]oleate, by well-characterized, Ca2 -tolerant dog and rat cardiomyocyte preparations using a technique that allowed accurate determination of initial influx rates; (b) to isolate and characterize a putative cardiac myocyte FABPPM; and (c) to examine its role in FFA uptake by means of antibody inhibition studies. A preliminary report of our findings has appeared in abstract form (16) .
Methods
Materials. D-[1-3H(N)]glucose (15.5 Ci/mmol) and 9,10-[3Hloleic acid Isolation of myocytes. Cardiac myocytes were isolated from dogs
(1-2-yr-old beagles) or rats (55-60-d-old Sprague Dawley) by collagenase perfusion in the presence of CaCl2 (7, 17) , and resuspended in Hepes-Ringer containing 3% BSA until use. Approximately 85-90% of all cells excluded trypan blue. Of these, up to 80% retained the rod shape. It has been previously shown that, with respect to specific physiologically relevant parameters, these myocytes are ultrastructurally, pharmacologically, and electrophysiologically indistinguishable from intact heart (7, 17) . Data presented below were obtained with canine cardiac myocytes except where the use of rat heart myocytes is specifically indicated. Incubation and uptakeprocedures. Forthe uptake studies myocytes were washed three times and resuspended (-1 X 106/ml) in Hanks' buffer containing 10 (20) . After dilution (1:1) and centrifugation (2,500 g for 30 min at 40C) the supernatant was passed through an oleate agarose affinity column (14) . After washing extensively with (14, 20) . The assay was performed on samples subjected to SDS-PAGE (20) .
Antibody inhibition studies. The role ofthe myocardial FABPpM in oleate uptake was examined by antibody inhibition studies employing the antibody to the rat liver FABPpM. To avoid possible immunologic and species differences, these studies were conducted with rat heart myocytes; the strong immunologic cross-reactivity between this antibody and rat heart FABPpM has been reported previously (20) . Isolated rat heart myocytes (1 X 106/ml, 1 ml) were incubated for 1 h at 4°C (Fig. 1 A) . Concentrations of BSA of 0.1% or higher virtually instantly removed surface-bound material followed by progressive effilux of intracellular radioactivity ( Fig. 1 B) . The combined 200 uM phloretin/0. 1% BSA stop solution removed surface material while blocking further effilux.
Initial oleate uptake reflects influx rather than dissociation from albumin or intracellular events. Over a wide range of absolute concentrations of oleate and BSA, the concentration of unbound oleate is precisely determined by the oleate/albumin molar ratio (18, 19) . Nevertheless, at low and nonphysiologic oleate/albumin concentrations the velocity of hepatocellular oleate uptake increases with increasing concentrations of substrate, despite a fixed molar ratio (22, 23). Recent experiments in isolated hepatocytes have shown that, for a given molar ratio, there exists a critical concentration of oleate:albumin beyond which further increases in the concentration of substrate complex produce no further increase in oleate uptake velocity (23); this maximal oleate uptake velocity for a given molar ratio was found to be a saturable function of the equilibrium unbound oleate concentrations defined by the various uptake velocity when measured at 370C (Fig. 3 ). As illustrated in Fig. 4 which all decrease hepatocellular uptake of oleate (9), had no effect in myocytes under the conditions employed. (20) (Fig. 5) . In contrast to the latter proteins, which are readily purified to homogeneity (20) , the canine protein was frequently accompanied by a contaminant of either slightly greater (Fig. 5) (Fig. 7) . (1), total canine myocardial membrane proteins (2) and proteins purified by oleate agarose affinity chromatography from dog heart (3) and rat liver (4), adipose tissue (5), jejunum (6) , and heart (7). MW, molecular weight (kD). (Right) Western blot of rat hepatocyte and canine myocyte FABPpM against the antibody to the rat hepatocyte FABPpM. The myocyte FABPpM, isolated by affinity chromatography, had been further purified by hydrophobic interaction HPLC.
weight, which appeared as a shoulder on the gel permeation HPLC elution peak (Fig. 6 A) . When further purified, as described, by hydrophobic interaction HPLC, the FABPpM eluted from the gel permeation column as a single, symmetrical peak at an elution time of 32.5 min. After incubation with
[3H]oleate, rechromatography of the eluted canine FABPpM through a 300 X 10-mm Superose-12 HPLC gel permeation column again yielded a symmetric peak which co-chromatographed with the labeled fatty acid; its retention time corresponded to a molecular weight of 40 kD (Fig. 6 B) . In addition to a molecular weight (40 kD) and isoelectric point (pI -9. 1) similar to those of the other FABPpM previously reported, the canine cardiac myocyte FABPpM gave a positive Western blot with a rabbit antiserum raised against the rat liver FABPpM (Fig. 5) .
Antibody inhibition studies At 37°C the antibody to rat liver FABPpM significantly inhibited uptake of [3H]oleate into isolated rat heart myocytes, compared to cells treated with preimmune serum (216±2 vs. 358±34 pmol/min per 50,000 cells, P < 0.02) (Fig. 7) . The degree of inhibition at 37°C (40%) was similar to that in adipocytes treated with corresponding antibody concentrations (12) . By contrast, the antibody had no effect compared to preimmune serum on nonspecific oleate uptake at 4°C, (2.7±0.10 vs. 2.9±0.9 pmol/min per 50,000 cells, P > 0.5). Antibody-treated cells retained their predominantly rod shape and viability. Specificity of the antibody effect for oleate trans-
Discussion
Fatty acid uptake by cardiac myocytes as well as other cell types was long considered by many (5, 6, 29-31) although not all investigators (3, 4) to occur by diffusion rather than by a specific facilitated process. Unfortunately, these earlier experiments with cardiac myocytes could not satisfactorily quantify FFA influx, since the techniques employed did not block efflux during sample preparation and the cells were prepared and used without calcium, which has been shown to alter sarcolemma integrity and permeability (7) .
More recently, we and others have shown that FFA uptake has the kinetic characteristics of a carrier-mediated process in hepatocytes (8, 9 ) and adipocytes (10) (11) (12) , and have isolated and characterized basic, 40-kD FABPpM from these and other tissues with high transmembrane fluxes of fatty acids (13, 14, 20) . That these proteins are similar and mediate FFA uptake has been clearly demonstrated. By immunofluorescence, an antibody raised in rabbits against the rat liver FABPpM bound specifically to the plasma membranes of cardiac myocytes, adipocytes, and jejunal enterocytes (12) (13) (14) . This antibody also inhibited oleate uptake, noncompetitively and in a dosedependent fashion, in rat hepatocytes (9), adipocytes (12) and, in preliminary studies, in the gut (15) . As these data collectively suggested that FFA might be taken up by the heart by mechanisms similar to those of liver, adipose tissue and gut, the current study, initiated in 1986 (16), focused on cardiac myocytes.
The cells employed, isolated from dog and rat, have been shown to resemble intact myocardium, functionally and morphologically, and to conform to the definition of "Ca2`-tolerant" (7, 17 on an average cell number of 40-50 X 106/g heart (7, 32) , it can be calculated that in vivo, at FFA/BSA molar ratios of -0.5:1 to 1:1, FFA influx approximates 1-1.5 nmol/min per 50,000 cells, a value three to five times larger than we observed in isolated cardiomyocytes. While other interpretations are possible, this discrepancy may indicate that FFA influx is dependent on the working load, and as a consequence, that the cardiomyocyte FFA requirements may be modulated at the membrane level. This conclusion is corroborated by the finding that, at low ventricular load, palmitate uptake rates in perfused rat heart are comparable to the data obtained in rat myocytes in the present study (33) .
Shortly after our initial characterization ofa rat myocardial FABPpM (20) (33) . Moreover, it is increasingly apparent that saturable uptake is a necessary but not sufficient criterion to establish that a transport process is carrier mediated (24) . In the current report we demonstrate that myocyte oleate uptake also displays countertransport and trans-stimulation, two other important features of carrier-mediated transport (27, 28) . Countertransport is typically established by demonstrating cellular effilux of labeled compound against the prevailing concentration gradient upon addition of unlabeled compound to the incubation mixture (27 negligible. Under these circumstances it would be possible to follow the effilux of the internalized label from the cell by measurements ofcellular radioactivity. These predictions were confirmed by the experiment illustrated in Fig. 4 A, which also shows that phloretin, which blocks membrane transport of oleate (Fig. 1) , virtually abolished the effilux of the labeled species. Furthermore, as expected (27) , [3H]oleate efflux rates under these conditions were trans-stimulated by increasing extracellular concentrations of unbound, unlabeled oleate (Fig. 4 B (14) , adipocytes (12, 20) , and jejunal enterocytes (13) . These proteins are unrelated structurally or immunologically to the family of cytosolic fatty acid binding proteins previously described in these tissues (38). The FABPpM of rat liver, gut, adipose tissue, and myocardium are closely related, if not identical (20) , and, in antibody inhibition studies, have now all been shown to play a crucial role in specific fatty acid uptake in their respective tissues (9, 12, 15) .
In the present study, an antibody against rat liver FABPpM gave a positive Western blot with the canine cardiac FABPpM and significantly inhibited specific [3H] oleate uptake by rat myocytes at 370C, while having no effect on nonspecific oleate uptake as measured at 4°C. Moreover, the antibody did not inhibit myocyte uptake of glucose, which has also been shown under similar conditions to be a specific carrier-mediated process (39), thus demonstrating the selectivity of the antibody effect.
Despite these similarities, the transport processes do not appear fully identical. Fatty acid uptake in liver and gut has been reported to be potential sensitive (40) , sodium coupled, and ouabain inhibitable (9, 15) . Recent, preliminary studies in the perfused liver suggest that oleate uptake is actively driven by both the electrical and sodium chemical gradients across the plasma membrane (41) . However, neither removal of external sodium nor ouabain nor metabolic inhibitors appear to inhibit significantly oleate uptake in adipocytes (10) (11) (12) ; the previously mentioned study by Stremmel (34) failed to demonstrate sodium dependence of myocyte oleate uptake; in the present study, substitution of external Na+ with Li', K+, choline, or sucrose in fact stimulated oleate uptake in cardiac myocytes. Previous observations in cultured chick embryo cardiac myocytes also indicated that fatty acid uptake occurs by a facilitation process without energy dependence (4). The basis for these differences remains to be determined. Preliminary studies conducted in our laboratory suggest (42) that the Na+ requirement of oleate uptake may be dependent on particular experimental conditions. Another possible explanation is that, as with the well-characterized 43-kD FABPpM of Escherichia coli (43, 44) , the FABPpM isolated thus far from mammalian tissues act as acceptors in more complex transport systems involving additional protein components. These additional transport components, and the consequent energy and ion requirements, could be tissue specific. These and other hypotheses are currently being explored.
Despite these questions, the preponderance of evidence from several laboratories now argues against the hypothesis that myocardial fatty acid uptake occurs by diffusion, and strongly suggests that the process is a facilitated one, mediated by a specific plasma membrane protein with high affinity for long-chain FFA, analogous to those isolated from liver, gut, and adipose tissue. Hence, both the absorption and the disposition of FFA may be subject to regulation at the level of the plasma membrane.
